Fractional flow reserve: lessons from PLATFORM and future perspectives

Gianluca Pontone, Patrizia Carità, Massimo Verdecchia, Dario Buccheri, Daniele Andreini, Andrea Igoren Guaricci, Mark G. Rabbat, Mauro Pepi

Research output: Contribution to journalArticle

Abstract

In the treatment of stable coronary artery disease (CAD) the identification of patients who may gain the highest benefit from further invasive treatments is of pivotal importance for the healthcare system. In this setting, it has been established that an ischemia-guided revascularization strategy yields improved clinical outcomes in a cost- effective fashion compared with anatomy-guided revascularization alone. Invasive fractional flow reserve (FFR) is considered the gold standard, especially in the intermediate-range atherosclerotic lesions, for assessing lesion specific ischemia at the time of invasive coronary angiography and has now become the standard of reference for studies assessing the diagnostic performance of the various non-invasive stress tests. Coronary computed tomography angiography (cCTA) is an increasingly utilized non-invasive test that enables direct anatomical visualization of CAD in the epicardial coronary arteries with excellent sensitivity and negative predictive value. However, cCTA alone has poor specificity with FFR. With advances in computational fluid dynamics, it is possible to derive FFR from cCTA datasets improving its positive predictive value and specificity. The aim of this review is to summarize the technical aspects of FFR-CT, clinical evidence and limitations behind the novel technology, with a special focus on the recent PLATFORM trial analyzing the effectiveness, clinical outcomes and resource utilization of FFR-CT. Finally, the future perspective of FFR-CT will be presented.

Original languageEnglish
JournalMinerva Cardioangiologica
Publication statusE-pub ahead of print - Nov 30 2016

Fingerprint

Coronary Artery Disease
Ischemia
Hydrodynamics
Coronary Angiography
Exercise Test
Anatomy
Coronary Vessels
Technology
Delivery of Health Care
Costs and Cost Analysis
Therapeutics
Computed Tomography Angiography
Datasets

Keywords

  • Journal Article

Cite this

Fractional flow reserve : lessons from PLATFORM and future perspectives. / Pontone, Gianluca; Carità, Patrizia; Verdecchia, Massimo; Buccheri, Dario; Andreini, Daniele; Guaricci, Andrea Igoren; Rabbat, Mark G.; Pepi, Mauro.

In: Minerva Cardioangiologica, 30.11.2016.

Research output: Contribution to journalArticle

Pontone, Gianluca ; Carità, Patrizia ; Verdecchia, Massimo ; Buccheri, Dario ; Andreini, Daniele ; Guaricci, Andrea Igoren ; Rabbat, Mark G. ; Pepi, Mauro. / Fractional flow reserve : lessons from PLATFORM and future perspectives. In: Minerva Cardioangiologica. 2016.
@article{564e551b541b462c8498b30f3fd88ee5,
title = "Fractional flow reserve: lessons from PLATFORM and future perspectives",
abstract = "In the treatment of stable coronary artery disease (CAD) the identification of patients who may gain the highest benefit from further invasive treatments is of pivotal importance for the healthcare system. In this setting, it has been established that an ischemia-guided revascularization strategy yields improved clinical outcomes in a cost- effective fashion compared with anatomy-guided revascularization alone. Invasive fractional flow reserve (FFR) is considered the gold standard, especially in the intermediate-range atherosclerotic lesions, for assessing lesion specific ischemia at the time of invasive coronary angiography and has now become the standard of reference for studies assessing the diagnostic performance of the various non-invasive stress tests. Coronary computed tomography angiography (cCTA) is an increasingly utilized non-invasive test that enables direct anatomical visualization of CAD in the epicardial coronary arteries with excellent sensitivity and negative predictive value. However, cCTA alone has poor specificity with FFR. With advances in computational fluid dynamics, it is possible to derive FFR from cCTA datasets improving its positive predictive value and specificity. The aim of this review is to summarize the technical aspects of FFR-CT, clinical evidence and limitations behind the novel technology, with a special focus on the recent PLATFORM trial analyzing the effectiveness, clinical outcomes and resource utilization of FFR-CT. Finally, the future perspective of FFR-CT will be presented.",
keywords = "Journal Article",
author = "Gianluca Pontone and Patrizia Carit{\`a} and Massimo Verdecchia and Dario Buccheri and Daniele Andreini and Guaricci, {Andrea Igoren} and Rabbat, {Mark G.} and Mauro Pepi",
year = "2016",
month = "11",
day = "30",
language = "English",
journal = "Minerva Cardioangiologica",
issn = "0026-4725",
publisher = "Edizioni Minerva Medica S.p.A.",

}

TY - JOUR

T1 - Fractional flow reserve

T2 - lessons from PLATFORM and future perspectives

AU - Pontone, Gianluca

AU - Carità, Patrizia

AU - Verdecchia, Massimo

AU - Buccheri, Dario

AU - Andreini, Daniele

AU - Guaricci, Andrea Igoren

AU - Rabbat, Mark G.

AU - Pepi, Mauro

PY - 2016/11/30

Y1 - 2016/11/30

N2 - In the treatment of stable coronary artery disease (CAD) the identification of patients who may gain the highest benefit from further invasive treatments is of pivotal importance for the healthcare system. In this setting, it has been established that an ischemia-guided revascularization strategy yields improved clinical outcomes in a cost- effective fashion compared with anatomy-guided revascularization alone. Invasive fractional flow reserve (FFR) is considered the gold standard, especially in the intermediate-range atherosclerotic lesions, for assessing lesion specific ischemia at the time of invasive coronary angiography and has now become the standard of reference for studies assessing the diagnostic performance of the various non-invasive stress tests. Coronary computed tomography angiography (cCTA) is an increasingly utilized non-invasive test that enables direct anatomical visualization of CAD in the epicardial coronary arteries with excellent sensitivity and negative predictive value. However, cCTA alone has poor specificity with FFR. With advances in computational fluid dynamics, it is possible to derive FFR from cCTA datasets improving its positive predictive value and specificity. The aim of this review is to summarize the technical aspects of FFR-CT, clinical evidence and limitations behind the novel technology, with a special focus on the recent PLATFORM trial analyzing the effectiveness, clinical outcomes and resource utilization of FFR-CT. Finally, the future perspective of FFR-CT will be presented.

AB - In the treatment of stable coronary artery disease (CAD) the identification of patients who may gain the highest benefit from further invasive treatments is of pivotal importance for the healthcare system. In this setting, it has been established that an ischemia-guided revascularization strategy yields improved clinical outcomes in a cost- effective fashion compared with anatomy-guided revascularization alone. Invasive fractional flow reserve (FFR) is considered the gold standard, especially in the intermediate-range atherosclerotic lesions, for assessing lesion specific ischemia at the time of invasive coronary angiography and has now become the standard of reference for studies assessing the diagnostic performance of the various non-invasive stress tests. Coronary computed tomography angiography (cCTA) is an increasingly utilized non-invasive test that enables direct anatomical visualization of CAD in the epicardial coronary arteries with excellent sensitivity and negative predictive value. However, cCTA alone has poor specificity with FFR. With advances in computational fluid dynamics, it is possible to derive FFR from cCTA datasets improving its positive predictive value and specificity. The aim of this review is to summarize the technical aspects of FFR-CT, clinical evidence and limitations behind the novel technology, with a special focus on the recent PLATFORM trial analyzing the effectiveness, clinical outcomes and resource utilization of FFR-CT. Finally, the future perspective of FFR-CT will be presented.

KW - Journal Article

M3 - Article

C2 - 27901333

JO - Minerva Cardioangiologica

JF - Minerva Cardioangiologica

SN - 0026-4725

ER -